Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:36:42 EDT Tue 13 May 2025
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - https://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - Q1.06.06·6.890.16.21+0.233.86,698.140,40219,2746.17  6.31  6.0912.65  5.8216:37:36May 0715 min RT 2¢

Recent Trades - Last 10 of 19274
Time ETExPriceChangeVolume
16:37:36Q6.210.233
16:20:00Q6.210.2344
16:18:57Q6.330.353
16:05:11Q6.210.231
16:03:08Q6.210.23172
16:02:50Q6.210.231,244
16:02:26Q6.210.231,177
16:02:16Q6.210.237,435
16:02:06Q6.210.232,796
16:02:06Q6.210.23187

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-07 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the Bank of America 2025 Health Care Conference
2025-05-01 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
2025-04-30 19:13U:FOLDNews ReleaseDimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
2025-04-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025
2025-02-27 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
2025-02-19 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
2025-02-10 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
2025-02-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium(TM) 2025
2025-01-12 16:00U:FOLDNews ReleaseAmicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook
2025-01-02 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-11-06 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
2024-11-01 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
2024-10-28 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
2024-10-17 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Settlement of Galafold(TM) (migalastat) Patent Litigation with Teva
2024-10-04 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024
2024-09-03 07:46U:FOLDNews ReleaseUPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
2024-09-03 07:05U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
2024-09-03 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium
2024-08-30 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
2024-08-08 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates